"Immunization and Infectious Diseases." Immunization and Infectious Diseases | Healthy People 2020. U.S. Department of Health and Human Services, 2014. Web. 07 Dec. 2016.

Human papillomavirus vaccination coverage among adolescent girls, 2007-2012, and postlicensure vaccine safety monitoring, 2006-2013—United States. Center for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2013; 62: 591-595Elam-Evans LD Yankey D Singleton JA et al.

National, Regional, State and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2019.

MMWR Morb Mortal Wkly Rep. 2020; 69: 1109-1116Walker TY Elam-Evans LD Singleton JA Yankey D Markowitz LE Fredua B et al.

National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2016.

MMWR Morb Mortal Wkly Rep. 2017; 66: 874-882Meties E Szilagyi PG Chesson HW Unger ER Romero JR Markowitz LE.

Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices.

MMWR Morb Mortal Wkly Rep. 2019; 68: 698-702Oliver SE Unger ER Lewis R McDaniel D Gargano JW Steinau M Markowitz LE.

Prevalence of Human Papillomavirus Among Females After Vaccine Introduction-National Health and Nutrition Examination Survey, United States, 2003-2014.

J Infect Dis. 2017; 216 (Sep 1): 594-603Rodriguez AC Solomon D Herrero R Hildesheim A Gonzalez P Wacholder S et al.

Impact of human papillomavirus vaccination on cervical cytology screening, colposcopy, and treatment.

Am J Epidemiol. 2013; 178: 752-760

Population Group Abortion Rates and Lifetime Incidence of Abortion: United States, 2008-2014.

Am J Public Health. 2017; 107: 1904-1909Lau JS Adams SH Park MJ Boscardin WJ Irwin CE.

Improvement in preventive care of young adults after the affordable care act: the affordable care act is helping.

JAMA Pediatr. 2014; 168: 1101-1106https://doi.org/10.1001/jamapediatrics.2014.1691

Perceptions of Health Care and Access to Preventive Services Among Young Adults.

J Community Health. 2017; 42 (Dec): 1204-1212Richards MJ Peters M Sheeder J.

Human Papillomavirus Vaccine: Continuation, Completion, and Missed Opportunities.

J Pediatr Adolesc Gynecol. 2016; 29: 117-121Oliveira CR Rock RM Shapiro ED Xu X Lundsberg L Zhang LB et al.

Missed opportunities for HPV immunization among young adult women.

Am J Obstet Gynecol. 2018; 218 (e1-.e7): 326O'Connell K Jones HE Simon M Saporta V Paul M Lichtenberg ES et al.

First-trimester surgical abortion practices: a survey of National Abortion Federation members.

Contraception. 2009; 79: 385-392Walling EB Benzoni N Dornfeld J Bhandari R Sisk BA Garbutt J et al.

Interventions to Improve HPV Vaccine Uptake: A Systematic Review.

Pediatrics. 2016; 138Berenson AB Rahman M Hirth JM Rupp RE Sarpong KO.

A human papillomavirus vaccination program for low-income postpartum women.

Am J Obstet Gynecol. 2016; 215 (e1-9): 318Cory L Cha B Ellenberg S Bogner HR Hwang WT Smith JS et al.

Effects of Educational Interventions on Human Papillomavirus Vaccine Acceptability: A Randomized Controlled Trial.

Obstet Gynecol. 2019; 134: 376-384Reiter PL Stubbs B Panozzo CA Whitesell D Brewer NT.

HPV and HPV vaccine education intervention: effects on parents, healthcare staff, and school staff.

Cancer Epidemiol Biomarkers Prev. 2011; 20 (Nov): 2354-2361Moss JL Reiter PL Rimer BK Brewer NT.

Collaborative patient-provider communication and uptake of adolescent vaccines.

Soc Sci Med. 2016; 159 (Jun): 100-107

Predictors of HPV vaccine acceptability: a theory-informed, systematic review.

Prev Med. 2007; 45: 107-114Simons HR Unger ZD Lopez PM Kohn JE.

Predictors of Human Papillomavirus Vaccine Completion Among Female and Male Vaccine Initiators in Family Planning Centers.

Am J Public Health. 2015; 105: 2541-2548Sankaranarayanan R Prabhu PR Pawlita M Gheit T Bhatla N Muwonge R et al.

Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study.

Lancet Oncol. 2016; 17: 67-77Berenson AB Hirth JM Chang M.

Change in Human Papillomavirus Prevalence Among U.S. Women Aged 18-59 Years, 2009-2014.

Obstet Gynecol. 2017; 130: 693-701Mehanna H Bryant TS Babrah J Louie K Bryant JL Spruce RJ et al.

Human Papillomavirus (HPV) Vaccine Effectiveness and Potential Herd Immunity for Reducing Oncogenic Oropharyngeal HPV-16 Prevalence in the United Kingdom: A Cross-sectional Study.

Clin Infect Dis. 2019; 69: 1296-1302Sonawane K Nyitray AG Nemutlu GS Swartz MD Chhatwal J Deshmukh AA.

Prevalence of Human Papillomavirus Infection by Number of Vaccine Doses Among US Women.

JAMA Netw Open. 2019; 2e1918571Newmann SJ Dufour MS McFarland W Oderman L Kellogg T Louie B et al.

HIV voluntary counseling and testing at an abortion clinic: missed opportunities for diagnosis.

Contraception. 2013; 88: 147-152Matulich M Cansino C Culwell KR Creinin MD.

Understanding women's desires for contraceptive counseling at the time of first-trimester surgical abortion.

Contraception. 2014; 89: 36-41Kavanaugh ML Carlin EE Jones RK.

Patients' attitudes and experiences related to receiving contraception during abortion care.

Contraception. 2011; 84: 585-593

“Medicaid Funding of Abortion.” Guttmacher Institute, 16 Feb. 2018, www.guttmacher.org/evidence-you-can-use/medicaid-funding-abortion.

“The HPV Vaccine: Access and Use in the U.S.” The Henry J. Kaiser Family Foundation, The Henry J. Kaiser Family Foundation, 19 Oct. 2017, www.kff.org/womens-health-policy/fact-sheet/the-hpv-vaccine-access-and-use-in/.

Waller J Ostini R Marlow LA McCaffery K Zimet G.

Validation of a measure of knowledge about human papillomavirus (HPV) using item response theory and classical test theory.

Prev Med. 2013; 56: 35-40Meites E Szilagyi PG Chesson HW Unger ER Romero JR Markowitz LE.

Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices.

MMWR Morb Mortal Wkly Rep. 2019; 68 (Aug 16PMID: 31415491; PMCID: PMC6818701): 698-702https://doi.org/10.15585/mmwr.mm6832a3

Practice Advisory: FDA Approval of 9-valent HPV Vaccine for Use in Women and Men Age 27-45. American College of Obstetircians and Gynecologists.

Obstet Gynecol. 2019;

“Clinical Services” (2015). Retrieved from https://www.plannedparenthood.org/files/9814/7275/8382/Clinical_Services_2016.pdf